Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study.
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsActivity of penciclovir against Epstein-Barr virusSevere thrombocytopenia as a complication of acute Epstein-Barr virus infection.Epstein-Barr virus induced thrombocytopenia treated with intravenous acyclovir and immunoglobulin.Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome.Acute cerebellar syndrome complicating infectious mononucleosis.Acyclovir for treatment of infectious mononucleosis: a meta-analysis.Antiviral agents for infectious mononucleosis (glandular fever).Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infectionEpstein-Barr virus infection and associated diseases in children. II. Diagnostic and therapeutic strategies.Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.Emerging therapies for herpes viral infections (types 1 - 8).Antiviral therapy: current concepts and practicesEffect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.Recent developments in the prevention and treatment of Epstein-Barr virus-associated lymphoproliferative diseases.The chronic fatigue syndrome: a return to common senseSubstrate specificity of Epstein-Barr virus thymidine kinase.Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.Epstein-Barr virus infection associated with interstitial nephritis and chronic fatigue.Therapeutic approaches for severe Epstein-Barr virus infection.Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.Antiviral therapy. New drugs and their uses.Evidence of tinidazole interference in the oropharyngeal inflammatory process during infectious mononucleosis.Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.Persistent preceding focal neurologic deficits in children with chronic Epstein-Barr virus encephalitis.Epstein-Barr virus associated aplastic anaemia and hepatitis.Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells.Could antiretrovirals be treating EBV in MS? A case report.New antiherpes drugs in development
P2860
Q24597706-37FE36B1-2698-4201-B073-CBCEA8F89022Q28367461-ED8FF47E-121F-4AB2-B5EA-C5B581B80CF9Q33360043-78048B3D-961D-431C-8C5F-D367BF382D49Q33418898-6F6AA246-1485-4EA1-B235-E0E16D085B7BQ33445634-15D1B22E-2506-4CD5-8E10-C6B5CD95F2C2Q33630077-5595BDFA-2CB6-4AC5-9351-7F6DE0B134EFQ33890661-51E931C9-1980-4CDE-897A-971935E1EF68Q34546950-7BD1B17D-8E9E-4BCE-A816-83D1D53E0468Q34590358-3D7DDE31-89F4-4DDB-B297-9EE1F7426F58Q35236967-19C754A5-8AA7-422E-818D-87A4B4CAD676Q35541334-83E734E9-C47D-4110-8CA6-815FA2F3E06CQ35967376-6DC25BEA-722B-42A8-A282-54A52C4694F4Q36070394-CCBBF22B-A9AE-46E9-A54C-526AD4AD6185Q37225916-DFDD2EDE-7854-4C11-B8B2-21595EAD5153Q37906623-2973BD00-2FA7-42A7-987A-9123AF259135Q37968491-DFE3EADB-73C6-40A3-9B3C-069FA587D0C8Q40286437-2E6EBC6B-1B02-449D-996D-CB915E0CD823Q40983855-65E17EBD-D261-495D-96D0-FFC5B364E545Q41101917-4E01C72B-2C47-4BF4-A26A-8BBD9DB98594Q41412514-BF416112-3FBB-457E-95EB-D8C7C760A7D8Q42717841-8CD2ED56-877C-4526-9885-F57895D8569FQ43669773-E12E6211-B149-45FA-90D5-0120D42E5E94Q44626002-A88C7ABA-A622-436A-B329-2D0781EC2B99Q44902399-24C1AA42-FD3B-478C-ACEA-83E8C15FF597Q45738589-27BD5675-2174-465F-AFF8-D24A60D5C7E1Q45779007-BC019A48-3950-46FD-8487-4FDE3F9CBAF8Q45788255-C8B8C0CE-99D5-40E4-AF13-99198F19C98FQ45835267-B5332741-22DD-4211-8400-F56A1DE53035Q45860999-D18BFA59-3EA2-4F7F-BA8F-C392147FAB65Q54261316-F38E216A-5E98-4955-AFFD-6212C742C932Q56864665-79AE3FEF-698B-4BCD-86B7-AF78FD5B5A0C
P2860
Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Effect of acyclovir on infecti ...... ind, placebo-controlled study.
@en
type
label
Effect of acyclovir on infecti ...... ind, placebo-controlled study.
@en
prefLabel
Effect of acyclovir on infecti ...... ind, placebo-controlled study.
@en
P2093
P356
P1476
Effect of acyclovir on infecti ...... ind, placebo-controlled study.
@en
P2093
P304
P356
10.1093/INFDIS/153.2.283
P407
P577
1986-02-01T00:00:00Z